Nurse Practitioner in Bigfork, MN Accepting Medicare
4 Nurse Practitioner nurses found. Showing 1 - 4
 Julie Anne Miller, FNP Nurse Practitioner - Family Medicare: Medicare Enrolled Practice Location: 135 Pine Tree Dr, Bigfork, MN 56628 Phone: 218-743-3232 |
Sabrina A Seyller, NP Nurse Practitioner - Family Medicare: Accepting Medicare Assignments Practice Location: 135 Pine Tree Dr, Bigfork, MN 56628 Phone: 218-743-3232 Fax: 218-743-4223 |
Denyse Sampson Trebs, RN-CANP Nurse Practitioner - Adult Health Medicare: Not Enrolled in Medicare Practice Location: 135 Pine Tree Dr, Bigfork, MN 56628 Phone: 218-743-3232 Fax: 218-743-4223 |
Elizabeth Marie Jacobson, Nurse Practitioner Medicare: Medicare Enrolled Practice Location: 135 Pine Tree Dr, Bigfork, MN 56628 Phone: 218-743-3232 |
News Archive
Are electronic medical records leading to higher medical bills?
Electronic medical records, long touted by government officials as a critical tool for cutting health care costs, appear to be prompting some doctors and hospitals to bill higher fees to Medicare for treating seniors.
ADAGES III study receives NIH grant to elucidate genetics of glaucoma in African descents
A study led by Robert N. Weinreb, chairman and Distinguished Professor of Ophthalmology at the University of California, San Diego School of Medicine, has received a $6.4 million, 5-year grant from the National Eye Institute, part of the National Institutes of Health, to elucidate the genetics of glaucoma in persons of African descent.
Specialist nurses boost parental willingness to consent to post-mortem research on children
Parents are mostly willing to consent to post mortem research on their children, providing they are approached by specialist nurses, experienced in bereavement and family counselling, suggests a small study published ahead of print in the Archives of Disease in Childhood.
Swine flu could come round again!
The Centres for Disease Protection and Control (CDC) says outbreaks of the new H1N1 swine flu continue to spread across the United States and the swine influenza virus is expected to spread to all 50 states and to cause many infections ranging from mild to severe.
Ferrer begins Lorediplon phase IIa trial in patients with insomnia disorder
Ferrer, a privately-held Spanish pharmaceutical company, today announces the first patient has been recruited into a phase IIa clinical trial to test the efficacy, safety and tolerability profile of Lorediplon in adult patients with insomnia disorder. The study is scheduled to be completed by Q4, 2016.
› Verified 2 days ago